XML 45 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
DISCLOSURES ABOUT THE FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
3 Months Ended
Mar. 31, 2018
Fair Value Disclosures [Abstract]  
Summary of carrying amount and estimated fair value of financial instruments
The carrying amounts and estimated fair values of the Company’s financial instruments as of March 31, 2018 and December 31, 2017 are summarized in the tables below.
March 31, 2018
 
Carrying
amounts
 
Estimated
fair values
($ in thousands)
 
 
Assets:
 
 
 
 
Fixed maturity securities available-for-sale:
 
 
 
 
U.S. treasury
 
$
7,956

 
$
7,956

U.S. government-sponsored agencies
 
302,476

 
302,476

Obligations of states and political subdivisions
 
293,931

 
293,931

Commercial mortgage-backed
 
76,660

 
76,660

Residential mortgage-backed
 
132,350

 
132,350

Other asset-backed
 
22,748

 
22,748

Corporate
 
420,352

 
420,352

Total fixed maturity securities available-for-sale
 
1,256,473

 
1,256,473

 
 
 
 
 
Equity investments, at fair value
 
 
 
 
Common stocks:
 
 
 
 
Financial services
 
44,895

 
44,895

Information technology
 
33,886

 
33,886

Healthcare
 
28,372

 
28,372

Consumer staples
 
14,715

 
14,715

Consumer discretionary
 
21,966

 
21,966

Energy
 
15,620

 
15,620

Industrials
 
25,235

 
25,235

Other
 
15,762

 
15,762

Non-redeemable preferred stocks
 
19,224

 
19,224

Investment funds
 
823

 
823

Total equity investments
 
220,498

 
220,498

 
 
 
 
 
Short-term investments
 
21,664

 
21,664

 
 
 
 
 
Liabilities:
 
 
 
 
Surplus notes
 
25,000

 
15,731

December 31, 2017
 
Carrying
amounts
 
Estimated
fair values
($ in thousands)
 
 
Assets:
 
 
 
 
Fixed maturity securities available-for-sale:
 
 
 
 
U.S. treasury
 
$
8,078

 
$
8,078

U.S. government-sponsored agencies
 
297,949

 
297,949

Obligations of states and political subdivisions
 
307,536

 
307,536

Commercial mortgage-backed
 
83,980

 
83,980

Residential mortgage-backed
 
119,799

 
119,799

Other asset-backed
 
24,114

 
24,114

Corporate
 
433,560

 
433,560

Total fixed maturity securities available-for-sale
 
1,275,016

 
1,275,016

 
 
 
 
 
Equity securities available-for-sale:
 
 
 
 
Common stocks:
 
 
 
 
Financial services
 
43,522

 
43,522

Information technology
 
35,810

 
35,810

Healthcare
 
30,595

 
30,595

Consumer staples
 
14,127

 
14,127

Consumer discretionary
 
20,538

 
20,538

Energy
 
16,905

 
16,905

Industrials
 
28,489

 
28,489

Other
 
16,421

 
16,421

Non-redeemable preferred stocks
 
21,708

 
21,708

Total equity securities available-for-sale
 
228,115

 
228,115

 
 
 
 
 
Short-term investments
 
23,613

 
23,613

 
 
 
 
 
Liabilities:
 
 
 
 
Surplus notes
 
25,000

 
16,689

Summary of assets and liabilities measured on recurring and non-recurring basis
Presented in the tables below are the estimated fair values of the Company’s financial instruments as of March 31, 2018 and December 31, 2017.
March 31, 2018
 
 
 
 
 
Fair value measurements using
($ in thousands)
 
Total
 
Investments measured at net asset value (NAV)
 
Quoted
prices in
active markets
for identical
assets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Financial instruments reported at fair value on recurring basis:
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
Fixed maturity securities available-for-sale:
 
 
 
 
 
 
 
 
 
 
U.S. treasury
 
$
7,956

 
$

 
$

 
$
7,956

 
$

U.S. government-sponsored agencies
 
302,476

 

 

 
302,476

 

Obligations of states and political subdivisions
 
293,931

 

 

 
293,931

 

Commercial mortgage-backed
 
76,660

 

 

 
76,660

 

Residential mortgage-backed
 
132,350

 

 

 
132,350

 

Other asset-backed
 
22,748

 

 

 
22,748

 

Corporate
 
420,352

 

 

 
419,790

 
562

Total fixed maturity securities available-for-sale
 
1,256,473

 

 

 
1,255,911

 
562

 
 
 
 
 
 
 
 
 
 
 
Equity investments, at fair value:
 
 
 
 
 
 
 
 
 
 
Common stocks:
 
 
 
 
 
 
 
 
 
 
Financial services
 
44,895

 

 
44,892

 

 
3

Information technology
 
33,886

 

 
33,886

 

 

Healthcare
 
28,372

 

 
28,372

 

 

Consumer staples
 
14,715

 

 
14,715

 

 

Consumer discretionary
 
21,966

 

 
21,966

 

 

Energy
 
15,620

 

 
15,620

 

 

Industrials
 
25,235

 

 
25,235

 

 

Other
 
15,762

 

 
15,762

 

 

Non-redeemable preferred stocks
 
19,224

 

 
9,443

 
9,781

 

Investment funds
 
823

 
823

 

 

 

Total equity investments
 
220,498

 
823

 
209,891

 
9,781

 
3

 
 
 
 
 
 
 
 
 
 
 
Short-term investments
 
21,664

 

 
21,664

 

 

 
 
 
 
 
 
 
 
 
 
 
Financial instruments not reported at fair value:
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
Surplus notes
 
15,731

 

 

 

 
15,731

December 31, 2017
 
 
 
 
 
Fair value measurements using
($ in thousands)
 
Total
 
Investments measured at net asset value (NAV)
 
Quoted
prices in
active markets
for identical
assets
(Level 1)
 
Significant
other
observable
inputs
(Level 2)
 
Significant
unobservable
inputs
(Level 3)
Financial instruments reported at fair value on recurring basis:
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
Fixed maturity securities available-for-sale:
 
 
 
 
 
 
 
 
 
 
U.S. treasury
 
$
8,078

 
$

 
$

 
$
8,078

 
$

U.S. government-sponsored agencies
 
297,949

 

 

 
297,949

 

Obligations of states and political subdivisions
 
307,536

 

 

 
307,536

 

Commercial mortgage-backed
 
83,980

 

 

 
83,980

 

Residential mortgage-backed
 
119,799

 

 

 
119,799

 

Other asset-backed
 
24,114

 

 

 
24,114

 

Corporate
 
433,560

 

 

 
432,940

 
620

Total fixed maturity securities available-for-sale
 
1,275,016

 

 

 
1,274,396

 
620

 
 
 
 
 
 
 
 
 
 
 
Equity securities available-for-sale:
 
 
 
 
 
 
 
 
 
 
Common stocks:
 
 
 
 
 
 
 
 
 
 
Financial services
 
43,522

 

 
43,519

 

 
3

Information technology
 
35,810

 

 
35,810

 

 

Healthcare
 
30,595

 

 
30,595

 

 

Consumer staples
 
14,127

 

 
14,127

 

 

Consumer discretionary
 
20,538

 

 
20,538

 

 

Energy
 
16,905

 

 
16,905

 

 

Industrials
 
28,489

 

 
28,489

 

 

Other
 
16,421

 

 
16,421

 

 

Non-redeemable preferred stocks
 
21,708

 

 
9,512

 
10,196

 
2,000

Total equity securities available-for-sale
 
228,115

 

 
215,916

 
10,196

 
2,003

 
 
 
 
 
 
 
 
 
 
 
Short-term investments
 
23,613

 

 
23,613

 

 

 
 
 
 
 
 
 
 
 
 
 
Financial instruments not reported at fair value:
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
Surplus notes
 
16,689

 

 

 

 
16,689

Reconciliation of assets measured at fair value on recurring basis using significant unobservable inputs
Presented in the table below is a reconciliation of the assets measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2018 and 2017.  Any unrealized gains or losses on these securities are recognized in other comprehensive income (loss).  Any gains or losses from settlements, disposals or impairments of these securities are reported as realized investment gains or losses in net income.
 
 
 
 
 
 
 
 
 
($ in thousands)
 
 
 
Fair value measurements using significant unobservable (Level 3) inputs
Three months ended March 31, 2018
 
 
 
Fixed maturity securities available-for-sale, corporate
 
Equity securities,
financial services
 
Total
Beginning balance
 
$
620

 
$
3

 
$
623

Settlements
 
(56
)
 

 
(56
)
Unrealized losses included in other comprehensive income (loss)
 
(2
)
 

 
(2
)
Balance at March 31, 2018
 
$
562

 
$
3

 
$
565


($ in thousands)
 
Fair value measurements using significant unobservable (Level 3) inputs
Three months ended March 31, 2017
 
Fixed maturity securities available-for-sale, corporate
 
Equity securities available-for-sale, financial services
 
Equity securities available-for-sale, non-redeemable preferred stocks
 
Total
Beginning balance
 
$
982

 
$
3

 
$
2,000

 
$
2,985

Settlements
 
(50
)
 

 

 
(50
)
Unrealized losses included in other comprehensive income (loss)
 
(3
)
 

 

 
(3
)
Balance at March 31, 2017
 
$
929

 
$
3

 
$
2,000

 
$
2,932